Patents by Inventor Antoine Nougairéde

Antoine Nougairéde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230181539
    Abstract: Coronaviridae is a family of enveloped, positive-sense, single-stranded RNA viruses. The emergence of a new beta-coronavirus SARS-CoV-2 has led to a major health-related crisis associated with a significant mortality in intensive care units, due to the pulmonary complications of COVID-19. The inventors showed that BAY-2402234 is suitable for inhibiting replication of coronavirus and thus would be suitable for the treatment of infections mediated by said type of virus.
    Type: Application
    Filed: May 19, 2021
    Publication date: June 15, 2023
    Inventors: Pierre-Olivier VIDALAIN, Antoine NOUGAIREDE, Franck TOURET, Patrice ANDRE, Vincent LOTTEAU, Xavier Nicolas LAMBALLERIE, Yves Louis JANIN
  • Publication number: 20230146096
    Abstract: Coronaviridae is a family of enveloped, positive-sense, single-stranded RNA viruses. The emergence of a new betacoronavirus SARS-CoV-2 has led to a major health-related crisis associated with a significant mortality in intensive care units, due to the pulmonary complications of COVID-19. The inventors showed that Vidofludimus is suitable for inhibiting replication of coronavirus and thus would be suitable for the treatment of infections mediated by said type of virus.
    Type: Application
    Filed: April 9, 2021
    Publication date: May 11, 2023
    Inventors: Pierre-Olivier VIDALAIN, Vincent LOTTEAU, Patrice ANDRE, Franck TOURET, Xavier Nicolas DE LAMBALLERIE, Antoine NOUGAIREDE
  • Publication number: 20200270584
    Abstract: The present invention harnesses the power of mutagenesis to produce an attenuated RNA virus in a very short period, i.e. as soon as the complete sequence of the target virus is known and an infectious genome can be produced.
    Type: Application
    Filed: March 9, 2020
    Publication date: August 27, 2020
    Inventors: Antoine Nougairéde, Lauriane De Fabritus, Fabien Aubry, Xavier De Lamballerie, Ernest Andrew Gould
  • Patent number: 10619137
    Abstract: The present invention harnesses the power of mutagenesis to produce an attenuated RNA virus in a very short period, i.e. as soon as the complete sequence of the target virus is known and an infectious genome can be produced.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: April 14, 2020
    Assignees: UNIVERSITÉ D'AIX-MARSEILLE, INSERM
    Inventors: Antoine Nougairéde, Lauriane De Fabritus, Fabien Aubry, Xavier De Lamballerie, Ernest Andrew Gould
  • Patent number: 10407667
    Abstract: The present invention relates to a method for rapid generation of an infectious RNA virus that completely eliminates the need of constructing a full-length c DNA, which covers the entire viral genome, cloning and propagating such full length c DNA.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: September 10, 2019
    Assignees: UNIVERSITÉ D'AIX-MARSEILLE, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)
    Inventors: Fabien Aubry, Antoine Nougairéde, Gilles Quérat, Xavier De Lamballerie, Ernest Andrew Gould, Lauriane De Fabritus
  • Publication number: 20180208907
    Abstract: The present invention relates to a method for rapid generation of an infectious RNA virus that completely eliminates the need of constructing a full-length c DNA, which covers the entire viral genome, cloning and propagating such full length c DNA.
    Type: Application
    Filed: June 19, 2015
    Publication date: July 26, 2018
    Inventors: Fabien Aubry, Antoine Nougairéde, Gilles Quérat, Xavier De Lamballerie, Ernest Andrew Gould, Lauriane De Fabritus
  • Publication number: 20180201908
    Abstract: The present invention harnesses the power of mutagenesis to produce an attenuated RNA virus in a very short period, i.e. as soon as the complete sequence of the target virus is known and an infectious genome can be produced.
    Type: Application
    Filed: June 19, 2015
    Publication date: July 19, 2018
    Inventors: Antoine Nougairéde, Lauriane De Fabritus, Fabien Aubry, Xavier De Lamballerie, Ernest Andrew Gould